Drug intelligence / Profile preview

Lactobacillus paracasei M-1

Development stage: Unknown
Modality: Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Administration: Oral

Overview

Lactobacillus paracasei M-1 refers to a specific strain of *Lactobacillus paracasei*, a gram-positive, heterofermentative species of lactic acid bacteria commonly utilized as a probiotic culture. While specific details for the 'M-1' strain are not widely available in public scientific literature, *Lactobacillus paracasei* in general is known for its ability to colonize the human intestinal tract and contribute to a balanced gut microbiome. Its mechanism of action involves enhancing food digestion, alleviating gastrointestinal discomfort, and supporting immune function by strengthening the intestinal barrier and increasing immune cell production. It also exhibits anti-inflammatory properties and can competitively inhibit the growth of harmful pathogens. *Lactobacillus paracasei* strains are frequently incorporated into dietary supplements and fermented foods due to their beneficial effects on digestive and immune health.

Beyond the preview

Go deeper on Lactobacillus paracasei M-1.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lactobacillus paracasei M-1.

Explore the full profile